Zepbound and Mounjaro are the two best-in-class products right now, says Dr. Scott Gottlieb

Поделиться
HTML-код
  • Опубликовано: 3 янв 2025

Комментарии • 6

  • @animen4165
    @animen4165 11 дней назад +2

    Forget advertising. Is there anything preventing Medicare or Medicaid from publishing prices of drugs they pay for?

  • @ChristopherLoupe-hh6bj
    @ChristopherLoupe-hh6bj 7 дней назад

    Just in zepbound has been approved for (whatever) isn’t that a shock? The fda never approves drugs that could potentially be dangerous ot ineffective. 😂. It should be breaking news when they don’t approve a big pharma drug

  • @harveypost7799
    @harveypost7799 10 дней назад

    Big holiday rush of cnbc ...bloomberg..